ASSETMARK, INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 138 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
ASSETMARK, INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$4,438,767
+1.1%
84,774
-21.5%
0.01%0.0%
Q1 2024$4,391,325
+12.9%
107,948
+2.6%
0.01%0.0%
Q4 2023$3,887,896
+65.5%
105,192
+71.1%
0.01%
+55.6%
Q3 2023$2,348,765
-16.5%
61,486
-21.1%
0.01%
-18.2%
Q2 2023$2,811,837
+95.3%
77,955
+106.8%
0.01%
+83.3%
Q1 2023$1,439,457
-13.7%
37,692
+28.5%
0.01%
-14.3%
Q4 2022$1,668,649
+65.9%
29,326
+15.2%
0.01%
+40.0%
Q3 2022$1,006,000
+947.9%
25,450
+1067.4%
0.01%
Q2 2022$96,000
+77.8%
2,180
+62.1%
0.00%
Q1 2022$54,000
-5.3%
1,345
-4.3%
0.00%
Q4 2021$57,000
+3.6%
1,406
+3.8%
0.00%
Q3 2021$55,000
-1.8%
1,355
+9.7%
0.00%
Q2 2021$56,000
+9.8%
1,2350.0%0.00%
Q1 2021$51,000
+27.5%
1,235
+32.8%
0.00%
Q4 2020$40,000930
+6100.0%
0.00%
Q4 2015$0
-100.0%
15
-92.5%
0.00%
Q4 2014$2,0002000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders